Comparison between Gujarat Kidney IPO and Park Medi World IPO.
Gujarat Kidney IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Park Medi World IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Gujarat Kidney IPO is up to ₹250.80 Cr whereas the issue size of the Park Medi World IPO is up to ₹920.00 Cr. The final issue price of Gujarat Kidney IPO is ₹114.00 per share and of Park Medi World IPO is ₹162.00 per share.
| Gujarat Kidney IPO | Park Medi World IPO | |
|---|---|---|
| Face Value | ₹2 per share | ₹2 per share |
| Issue Price (Lower) | ₹108.00 per share | ₹154.00 per share |
| Issue Price (Upper) | ₹114.00 per share | ₹162.00 per share |
| Issue Price (Final) | ₹114.00 per share | ₹162.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 128 shares | 92 shares |
| Fresh Issue Size | 2,20,00,000 shares | 4,75,30,864 shares |
| Fresh Issue Size (Amount) | up to ₹250.80 Cr | up to ₹770.00 Cr |
| OFS Issue Size | 0 shares | 92,59,259 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹150.00 Cr |
| Issue Size Total | 2,20,00,000 shares | 5,67,90,123 shares |
| Issue Size Total (Amount) | up to ₹250.80 Cr | up to ₹920.00 Cr |
Gujarat Kidney IPO opens on Dec 22, 2025, while Park Medi World IPO opens on Dec 10, 2025. The closing date of Gujarat Kidney IPO and Park Medi World IPO is Dec 24, 2025, and Dec 12, 2025, respectively.
| Gujarat Kidney IPO | Park Medi World IPO | |
|---|---|---|
| Anchor Bid Date | Dec 19, 2025 | Dec 09, 2025 |
| Issue Open | Dec 22, 2025 | Dec 10, 2025 |
| Issue Close | Dec 24, 2025 | Dec 12, 2025 |
| Basis Of Allotment (Tentative) | Dec 26, 2025 | Dec 15, 2025 |
| Initiation of Refunds (Tentative) | Dec 29, 2025 | Dec 16, 2025 |
| Credit of Share (Tentative) | Dec 29, 2025 | Dec 16, 2025 |
| Listing date (Tentative) | Dec 30, 2025 | Dec 17, 2025 |
| Anchor Lockin End date 1 | Jan 24, 2026 | Jan 13, 2026 |
| Anchor Lockin End date 2 | Mar 25, 2026 | Mar 14, 2026 |
Gujarat Kidney IPO P/E ratio is 61.62, as compared to Park Medi World IPO P/E ratio of 29.21.
| Gujarat Kidney IPO | Park Medi World IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)Gujarat Kidney & Super Speciality Ltd.'s revenue increased by 637% and profit after tax (PAT) rose by 454% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated Consolidated)Park Medi World Ltd.'s revenue increased by 13% and profit after tax (PAT) rose by 40% between the financial year ending with March 31, 2025 and March 31, 2024.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 99.1 | 95.55 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 71.45 | 82.89 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 61.62 | 29.21 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹898.81 Cr. | ₹6997.28 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 36.61% | 20.68% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 37.65% | 17.47% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.15 | 0.61 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹1.85 | ₹5.55 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 36.61% | 20.08% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Gujarat Kidney IPO Retail Individual Investors (RII) are offered 22,00,000 shares while in Park Medi World IPO retail investors are offered 22,00,000 shares. Qualified Institutional Buyers (QIB) are offered 77,26,880 shares in Gujarat Kidney IPO and 1,13,58,024 shares in Park Medi World IPO.
| Gujarat Kidney IPO | Park Medi World IPO | |
|---|---|---|
| Anchor Investor Reservation | 87,73,120 shares | 1,70,37,036 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 77,26,880 shares | 1,13,58,024 shares |
| NII | 33,00,000 shares | 85,18,519 shares |
| RII | 22,00,000 shares | 1,98,76,544 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 2,20,00,000 shares | 5,67,90,123 shares |
Gujarat Kidney IPO subscribed 5.21x in total, whereas Park Medi World IPO subscribed 8.52x.
| Gujarat Kidney IPO | Park Medi World IPO | |
|---|---|---|
| QIB (times) | 1.06x | 12.07x |
| NII (times) | 5.73x | 15.93x |
| Big NII (times) | 5.25x | 18.34x |
| Small NII (times) | 6.68x | 11.12x |
| RII (times) | 19.04x | 3.32x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 5.21x | 8.52x |
